ER signaling was significantly higher in IHC-based HR-subtype breast cancer samples (Figure 2A) but was low in IHC-based HR-subtype EMPD, likely explaining the discrepancy between the IHC-based and PAM50-based classification for HR in EMPD (Figure 2A). The gene discussed is ESR1; the disease is breast cancer.